BENEFICIAL EFFECTS OF LUSEOGLIFLOZIN FOR HEPATIC STEATOSIS AND FIBROSIS INDEXES WITH A REDUCTION OF BODY WEIGHT AND AN INCREASE IN SERUM ALBUMIN LEVELS IN PATIENTS WITH DIABETES: A POOLED META- ANALYSIS OF PHASE I I I CLINICAL TRIALS USING INVERSE PROBABILITY TREATMENT WEIGHTING PROPENSITY ANALYSIS

被引：0

作者：

Kawaguchi, Takumi ^{[1
,2
]}

Murotani, Kenta ^{[2
,3
]}

Shirouzu, Yoko ^{[4
]}

Obara, Hitoshi ^{[3
]}

Yamaguchi, Hironori ^{[4
]}

Toyofuku, Yuko ^{[2
]}

Kaneko, Fumi ^{[2
]}

Uchida, Saeko ^{[4
]}

机构：

[1] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan

[2] Kurume Univ Hosp, Kurume, Fukuoka, Japan

[3] Kurume Univ, Kurume, Fukuoka, Japan

[4] Taisho Pharmaceut Co Ltd, Tokyo, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2425- C

引用

页码：S1174 / S1175

页数：2